ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.02%
US Dollar vs AUD
1.53069
-0.15%
Bitcoin
63,815.63
-1.04%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) News

ALVO Alvontech

14.15
0.50 (3.66%)
After Hours
Last Updated: 06:02:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Alvontech ALVO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.50 3.66% 14.15 06:02:01
Open Price Low Price High Price Close Price Previous Close
14.14 14.00 14.23 14.15 13.65
more quote information »

Recent News

Date Time Source Heading
24/4/202418:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19/4/202420:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
17/4/202407:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
17/4/202407:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03/4/202422:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
23/3/202407:15GLOBEAlvotech Announces Increase in Number of Own Shares
21/3/202407:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20/3/202422:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
06/3/202408:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
01/3/202408:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26/2/202420:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
24/2/202412:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/2/202412:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15/2/202422:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29/1/202420:00GLOBEAlvotech Announces Positive Top-Line Results from a..
20/1/202404:31DJNAlvotech Shares Climb After FDA Concludes Facility..
20/1/202403:30GLOBEAlvotech Provides Update on Status of Biologics License..
10/1/202419:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
03/1/202419:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
29/11/202320:00GLOBEAlvotech Announces Positive Top-Line Results from a..
29/11/202308:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
22/11/202300:00GLOBEAlvotech to Report Financial Results for the First Nine..
14/11/202323:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
11/11/202301:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
08/11/202300:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
12/10/202319:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
03/10/202323:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
03/10/202320:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
25/9/202318:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
20/9/202318:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
05/9/202323:30GLOBEAlvotech Announces Changes to the Leadership Team
31/8/202306:15GLOBEAlvotech Reports Financial Results for First Six Months of..
29/8/202319:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
22/8/202323:15GLOBEAlvotech to Report Financial Results for the First Half of..
31/7/202318:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
24/7/202318:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
03/7/202323:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
29/6/202310:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
29/6/202309:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
12/6/202321:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
12/6/202317:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
31/5/202319:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
24/5/202319:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
19/5/202319:00GLOBEAlvotech Reports Financial Results for First three Months of..
17/5/202319:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
15/5/202319:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
10/5/202319:00GLOBEAlvotech enters into commercialization agreement with..
04/5/202319:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
03/5/202323:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

Your Recent History

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved